Source: Global Legal Chronicle

Taibang: Taibang Biologic Group's $300 Million Equity Raising

Davis Polk advised Taibang Biologic Group on the transaction. Taibang Biologic Group (previously listed as China Biologic Products Holdings on the Nasdaq Global Select Market under [...]

Read full article »
Taibang's Competitors | Taibang's News | Taibang's Financials
Stay up-to-date with the latest news on Taibang Biologic Group
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Joseph Chow's photo - Chairman & CEO of Taibang Biologic Group

Chairman & CEO

Joseph Chow

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Taibang Biologic Group